Initiatives aim to reduce residents' high rates of depression and increase self-care skills.
Jessica Russo, PharmD, MBA
Advertisement
Articles by Jessica Russo, PharmD, MBA
The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
FDA, HHS Move to Accelerate Biosimilar Approvals
4
Court Ruling Highlights Risks of Improper Dose Adjustments
5
